Related Experiment Video
Updated: May 12, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Novel STXBP1 mutations in 2 patients with early infantile epileptic encephalopathy
Mafalda Sampaio1, Ruben Rocha2, Saskia Biskup3
1Pediatric Neurology Department, Hospital Pediátrico Integrado, Centro Hospitalar São João, Porto, Portugal mafaldansampaio@gmail.com.
Insights
STXBP1 gene mutations are a rare cause of early infantile epileptic encephalopathy. Genetic testing for STXBP1 should be considered in infants with severe epilepsy, after ruling out other common genetic causes.
Area of Science:
- Genetics
- Neuroscience
- Pediatric Neurology
Background:
- Early infantile epileptic encephalopathy (EIEE) is a severe form of epilepsy presenting within the first six months of life.
- Genetic factors play a significant role in the etiology of EIEE, with several genes identified as causative.
- STXBP1 gene mutations have been identified as a rare cause of EIEE, but their full spectrum and clinical significance are still being elucidated.
Observation:
- This study reports on two patients diagnosed with EIEE due to novel mutations in the STXBP1 gene.
- The patients presented with distinct clinical phenotypes, highlighting the variability associated with STXBP1 mutations.
- Detailed molecular analysis identified two previously undescribed mutations within the STXBP1 gene.
Findings:
- Novel STXBP1 mutations were identified as the cause of EIEE in two unrelated patients.
- The findings support the inclusion of STXBP1 gene analysis in the diagnostic workup for EIEE, particularly after excluding mutations in ARX (in males) and CDKL5 (in females).
- Mechanisms underlying the variable clinical presentations in patients with STXBP1 mutations were discussed.
Implications:
- The study proposes an updated genetic classification for early-onset epileptic encephalopathies, emphasizing those beginning in the first six months of life.
- This research underscores the importance of comprehensive genetic testing in diagnosing rare epilepsies.
- Further research into STXBP1 mutations may lead to improved understanding and targeted therapies for EIEE.
Abstract:
The authors describe 2 patients with early infantile epileptic encephalopathy caused by 2 novel mutations involving the STXBP1 gene. The authors suggest that in spite of the rarity of STXBP1 mutations, molecular analysis of STXBP1 gene should be performed in patients with early infantile epileptic encephalopathy, after exclusion of ARX mutations in male patients and CDKL5 mutations in female patients. The potential mechanisms explaining the variable clinical phenotypes caused by STXBP1 mutations are discussed and the designation of early-onset epileptic encephalopathies, including an updated genetic classification, is proposed to encompass the epileptic encephalopathies beginning in the first 6 months of life.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017